Breaking News Instant updates and real-time market news.

2020-04-22 05:42:05 BNTX BioNTech $42.40 / -1.25 (-2.86%) , PFE Pfizer $35.64 / -0.44 (-1.22%) 05:42 04/22/20 04/22 05:42 04/22/20 05:42	BioNTech, Pfizer receive German regulatory approval for COVID-19 vaccine trial BioNTech SE (BNTX) and Pfizer (PFE) have announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the Phase 1/2 clinical trial for BioNTech's BNT162 vaccine program to prevent COVID-19 infection. BioNTech and Pfizer are jointly developing BNT162. The trial is the first clinical trial of a COVID-19 vaccine candidate to start in Germany, and is part of a global development program. Pfizer and BioNTech will also conduct trials for BNT162 in the United States upon regulatory approval, which is expected shortly. The four vaccine candidates are the first candidates from BioNTech's COVID-19-focused project "Lightspeed", each representing different mRNA formats and target antigens. Two of the four vaccine candidates include a nucleoside modified mRNA, or modRNA, one includes a uridine containing mRNA, or uRNA, and the fourth vaccine candidate utilizes self-amplifying mRNA, or saRNA. Each mRNA format is combined with a lipid nanoparticle, or LNP, formulation. The larger spike sequence is included in two of the vaccine candidates, and the smaller optimized receptor binding domain, or RBD, from the spike protein is included in the other two candidates. The RBD-based candidates contain the piece of the spike that is thought to be most important for eliciting antibodies that can inactivate the virus. BNTX BioNTech $42.40 / -1.25 (-2.86%) PFE Pfizer $35.64 / -0.44 (-1.22%)	23 Apr 28 Apr 04 May
BNTX PFE BNTX BioNTech $42.40 / -1.25 (-2.86%) 04/13/20 H.C. Wainwright BioNTech price target raised to $48 from $30 at H.C. Wainwright 04/03/20 Canaccord BioNTech price target raised to $60 from $22 at Canaccord 03/18/20 JPMorgan JPMorgan downgrades BioNTech to Neutral after COVID-19 rally 03/18/20 JPMorgan BioNTech downgraded to Neutral from Overweight at JPMorgan PFE Pfizer $35.64 / -0.44 (-1.22%) 03/25/20 Piper Sandler Piper Sandler sees FY20 U.S. sales of Opko's Rayaldee at $52.5M 02/27/20 Standpoint Research Pfizer upgraded to Buy from Hold at Standpoint Research 02/27/20 Barclays Pfizer initiated with an Equal Weight at Barclays

2020-04-22 05:42:05

BNTX

BioNTech

$42.40 / -1.25 (-2.86%)

, PFE

Pfizer

$35.64 / -0.44 (-1.22%)

05:42

04/22/20

04/22

05:42

04/22/20

05:42

BioNTech, Pfizer receive German regulatory approval for COVID-19 vaccine trial

BioNTech SE (BNTX) and Pfizer (PFE) have announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the Phase 1/2 clinical trial for BioNTech's BNT162 vaccine program to prevent COVID-19 infection. BioNTech and Pfizer are jointly developing BNT162. The trial is the first clinical trial of a COVID-19 vaccine candidate to start in Germany, and is part of a global development program. Pfizer and BioNTech will also conduct trials for BNT162 in the United States upon regulatory approval, which is expected shortly. The four vaccine candidates are the first candidates from BioNTech's COVID-19-focused project "Lightspeed", each representing different mRNA formats and target antigens. Two of the four vaccine candidates include a nucleoside modified mRNA, or modRNA, one includes a uridine containing mRNA, or uRNA, and the fourth vaccine candidate utilizes self-amplifying mRNA, or saRNA. Each mRNA format is combined with a lipid nanoparticle, or LNP, formulation. The larger spike sequence is included in two of the vaccine candidates, and the smaller optimized receptor binding domain, or RBD, from the spike protein is included in the other two candidates. The RBD-based candidates contain the piece of the spike that is thought to be most important for eliciting antibodies that can inactivate the virus.

BNTX

BioNTech

$42.40 / -1.25 (-2.86%)

PFE

Pfizer

$35.64 / -0.44 (-1.22%)

23
Apr
28
Apr
04
May

BNTX
PFE

BNTX BioNTech

$42.40 / -1.25 (-2.86%)

04/13/20 H.C. Wainwright: BioNTech price target raised to $48 from $30 at H.C. Wainwright

04/03/20 Canaccord: BioNTech price target raised to $60 from $22 at Canaccord

03/18/20 JPMorgan: JPMorgan downgrades BioNTech to Neutral after COVID-19 rally

03/18/20 JPMorgan: BioNTech downgraded to Neutral from Overweight at JPMorgan

PFE Pfizer

$35.64 / -0.44 (-1.22%)

03/25/20 Piper Sandler: Piper Sandler sees FY20 U.S. sales of Opko's Rayaldee at $52.5M

02/27/20 Standpoint Research: Pfizer upgraded to Buy from Hold at Standpoint Research

02/27/20 Barclays: Pfizer initiated with an Equal Weight at Barclays

TODAY'S FREE FLY STORIES

Recommendations	Transcontinental price target raised to C$25 from C$23 at RBC Capital » 13:56 02/26/21 02/26 13:56 02/26/21 13:56 TCLAF Transcontinental $0.00 / + (+0.00%) RBC Capital analyst Drew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TCLAF Transcontinental $0.00 / + (+0.00%) 12/11/20 Canaccord Transcontinental price target raised to C$23 from C$20 at Canaccord 12/11/20 BMO Capital Transcontinental price target raised to C$21 from C$17.50 at BMO Capital 12/11/20 CIBC Transcontinental price target raised to C$25 from C$19 at CIBC 12/11/20 RBC Capital Transcontinental price target raised to C$23 from C$22 at RBC Capital
Recommendations	Toronto-Dominion price target raised to C$82 from C$79 at RBC Capital » 13:56 02/26/21 02/26 13:56 02/26/21 13:56 TD Toronto-Dominion $60.92 / -1.09 (-1.76%) RBC Capital analyst Darko… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals TD Toronto-Dominion $60.92 / -1.09 (-1.76%) 02/25/21 Toronto-Dominion reports Common Equity Tier 1 Capital ratio 13.6% 02/18/21 State Street appoints Theresa McLaughlin as global CMO 01/14/21 TD Bank Group to acquire Wells Fargo's Canadian Direct Equipment Finance unit 12/03/20 Toronto-Dominion reports Common Equity Tier 1 Capital ratio 13.1% TD Toronto-Dominion $60.92 / -1.09 (-1.76%) 13:47 Today CIBC Toronto-Dominion price target raised to C$88 from C$84 at CIBC 13:17 Today National Bank Toronto-Dominion price target raised to C$82 from C$75 at National Bank 12:40 Today Scotiabank Toronto-Dominion price target raised to C$91 from C$82 at Scotiabank 02/17/21 Scotiabank Toronto-Dominion price target raised to C$82 from C$80 at Scotiabank TD Toronto-Dominion $60.92 / -1.09 (-1.76%) 02/25/21 Toronto-Dominion reports Q1 adjusted EPS C$1.83 vs. C$1.66 last year 12/03/20 Toronto-Dominion reports Q4 adjusted EPS C$1.60 vs. C$1.59 last year 08/27/20 Toronto-Dominion reports Q3 adjusted EPS C$1.25 vs. C$1.79 last year TD Toronto-Dominion $60.92 / -1.09 (-1.76%) 01/29/21 TD customers hit with fradulent DoorDash charges, CBC reports
Recommendations	Stantec price target raised to C$48 from C$45 at RBC Capital » 13:56 02/26/21 02/26 13:56 02/26/21 13:56 STN Stantec $39.67 / +0.9 (+2.32%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings STN Stantec $39.67 / +0.9 (+2.32%) 02/23/21 Stantec and Hensel Phelps selected by WMATA for $225M project 02/16/21 Stantec signs agreement to acquire GTA Consultants 12/03/20 Stantec signs LOI to acquire Wenck environmental engineering firm 11/24/20 Stantec selected for PDS services for new South Niagara Hospital in Ontario STN Stantec $39.67 / +0.9 (+2.32%) 13:46 Today CIBC Stantec price target raised to C$56 from C$52 at CIBC 12:39 Today Scotiabank Stantec price target raised to C$59 from C$57 at Scotiabank 11:28 Today TD Securities Stantec price target raised to C$60 from C$50 at TD Securities 02/11/21 Scotiabank Stantec price target raised to C$57 from C$46 at Scotiabank STN Stantec $39.67 / +0.9 (+2.32%) 11/04/20 Stantec sees FY20 revenues slightly below FY19 level 11/04/20 Stantec reports Q3 EPS 62c, consensus 35c
Recommendations	Secure Energy price target raised to C$5 from C$4.75 at RBC Capital » 13:55 02/26/21 02/26 13:55 02/26/21 13:55 SECYF Secure Energy $0.00 / + (+0.00%) RBC Capital analyst Keith… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SECYF Secure Energy $0.00 / + (+0.00%) 11:28 Today TD Securities Secure Energy price target raised to C$4 from C$3.50 at TD Securities 01/27/21 National Bank Secure Energy price target raised to C$4 from C$2.50 at National Bank 01/19/21 CIBC Secure Energy initiated with an Outperformer at CIBC 01/15/21 Raymond James Secure Energy price target raised to C$4 from C$3 at Raymond James
Recommendations	Quebecor price target raised to C$39 from C$38 at RBC Capital » 13:55 02/26/21 02/26 13:55 02/26/21 13:55 QBCRF Quebecor $0.00 / + (+0.00%) RBC Capital analyst Drew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research QBCRF Quebecor $0.00 / + (+0.00%) 13:46 Today CIBC Quebecor price target raised to C$40 from C$38 at CIBC 12:33 Today Scotiabank Quebecor price target raised to C$39 from C$38 at Scotiabank 01/06/21 Canaccord Quebecor downgraded to Hold from Buy at Canaccord 11/06/20 CIBC Quebecor price target raised to C$38 from C$36 at CIBC

Recommendations	Pason Systems price target raised to C$12 from C$10 at RBC Capital » 13:54 02/26/21 02/26 13:54 02/26/21 13:54 PSYTF Pason Systems $0.00 / + (+0.00%) RBC Capital analyst Keith… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research PSYTF Pason Systems $0.00 / + (+0.00%) 13:13 Today National Bank Pason Systems price target raised to C$11 from C$10.50 at National Bank 01/15/21 National Bank Pason Systems upgraded to Outperform from Sector Perform at National Bank 11/19/20 Barclays Pason Systems initiated with an Overweight at Barclays 08/21/20 RBC Capital Pason Systems initiated with a Sector Perform at RBC Capital
Recommendations	Maple Leaf Foods price target raised to C$36 from C$33 at RBC Capital » 13:53 02/26/21 02/26 13:53 02/26/21 13:53 MLFNF Maple Leaf Foods $0.00 / + (+0.00%) RBC Capital analyst Irene… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research MLFNF Maple Leaf Foods $0.00 / + (+0.00%) 13:43 Today CIBC Maple Leaf Foods price target raised to C$37 from C$35 at CIBC 12:31 Today Scotiabank Maple Leaf Foods price target raised to C$36.50 from C$34 at Scotiabank 02/01/21 RBC Capital Maple Leaf Foods price target lowered to C$33 from C$34 at RBC Capital 10/28/20 BMO Capital Maple Leaf Foods upgraded to Outperform from Market Perform at BMO Capital
Recommendations	Loblaw price target lowered to C$91 from C$95 at RBC Capital » 13:53 02/26/21 02/26 13:53 02/26/21 13:53 LBLCF Loblaw $0.00 / + (+0.00%) RBC Capital analyst Irene… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research LBLCF Loblaw $0.00 / + (+0.00%) 13:43 Today CIBC Loblaw price target lowered to C$78 from C$82 at CIBC 12:29 Today Scotiabank Loblaw price target lowered to C$72 from C$76 at Scotiabank 02/04/21 National Bank Loblaw price target lowered to C$76 from C$82 at National Bank 01/22/21 RBC Capital Loblaw price target lowered to C$95 from C$106 at RBC Capital
Recommendations	Enerflex price target raised to C$12 from C$11 at RBC Capital » 13:52 02/26/21 02/26 13:52 02/26/21 13:52 ENRFF Enerflex $0.00 / + (+0.00%) RBC Capital analyst Keith… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ENRFF Enerflex $0.00 / + (+0.00%) 13:42 Today CIBC Enerflex price target raised to C$9.50 from C$8.50 at CIBC 13:12 Today National Bank Enerflex price target raised to C$10.50 from C$10 at National Bank 02/25/21 Raymond James Enerflex price target raised to C$9.50 from C$8.50 at Raymond James 01/19/21 CIBC Enerflex initiated with a Neutral at CIBC
Recommendations	ECN Capital price target raised to EUR 11 from EUR 10 at RBC Capital » 13:52 02/26/21 02/26 13:52 02/26/21 13:52 ECNCF ECN Capital $0.00 / + (+0.00%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ECNCF ECN Capital $0.00 / + (+0.00%) 13:40 Today CIBC ECN Capital price target raised to C$9.50 from C$9 at CIBC 11:26 Today TD Securities ECN Capital price target raised to C$10 from C$9 at TD Securities 02/24/21 BMO Capital ECN Capital price target raised to C$9.50 from C$8.50 at BMO Capital 02/22/21 Credit Suisse ECN Capital initiated with an Outperform at Credit Suisse

Recommendations	CCL Industries price target raised to C$80 from C$77 at RBC Capital » 13:51 02/26/21 02/26 13:51 02/26/21 13:51 CCDBF CCL Industries $0.00 / + (+0.00%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CCDBF CCL Industries $0.00 / + (+0.00%) 12/21/20 CCL Industries releases 2019 sustainability report 11/30/20 CCL Industries announces closing of Super Enterprises acquisition 11/09/20 CCL Industries expands in Malaysia 11/02/20 CCL Industries announces plans for capacity investment at Innovia Films unit CCDBF CCL Industries $0.00 / + (+0.00%) 13:40 Today CIBC CCL Industries price target raised to C$75 from C$72 at CIBC 12:17 Today Scotiabank CCL Industries price target raised to C$77 from C$72 at Scotiabank 11:23 Today TD Securities CCL Industries price target raised to C$75 from C$68 at TD Securities 02/19/21 CIBC CCL Industries price target raised to C$72 from C$70 at CIBC CCDBF CCL Industries $0.00 / + (+0.00%) 11/13/20 CCL Industries reports Q3 adj. EPS C$0.93 vs. C$0.72 last year
Recommendations	Cascades price target raised to C$20 from C$18 at RBC Capital » 13:51 02/26/21 02/26 13:51 02/26/21 13:51 CADNF Cascades $0.00 / + (+0.00%) RBC Capital analyst Paul… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CADNF Cascades $0.00 / + (+0.00%) 11:22 Today TD Securities Cascades price target raised to C$19 from C$18.50 at TD Securities 02/11/21 Scotiabank Cascades price target raised to C$19 from C$18 at Scotiabank 02/01/21 National Bank Cascades price target raised to C$22.50 from C$21 at National Bank 01/21/21 BMO Capital Cascades initiated with an Outperform at BMO Capital
Recommendations	CIBC price target raised to C$141 from C$130 at RBC Capital » 13:50 02/26/21 02/26 13:50 02/26/21 13:50 CM CIBC $93.05 / -0.6 (-0.64%) RBC Capital analyst Darko… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CM CIBC $93.05 / -0.6 (-0.64%) 02/03/21 CIBC says sale of majority stake in FirstCaribbean will not proceed 12/03/20 CIBC appoints Katharine Stevenson as chair of the board 09/01/20 CIBC appoints Kikelomo Lawal as EVP, Chief Legal Officer CM CIBC $93.05 / -0.6 (-0.64%) 13:11 Today National Bank CIBC price target raised to C$130 from C$126 at National Bank 12:18 Today Scotiabank CIBC price target raised to C$144 from C$139 at Scotiabank 11:32 Today TD Securities CIBC price target raised to C$130 from C$125 at TD Securities 05:07 Today BMO Capital CIBC upgraded to Outperform from Market Perform at BMO Capital CM CIBC $93.05 / -0.6 (-0.64%) 12/03/20 CIBC reports Q4 adjusted EPS C$2.79 vs. C$2.84 last year 08/27/20 CIBC reports Q3 adj EPS C$2.71 vs. C$3.10 last year
Recommendations	Boralex price target lowered to C$50 from C$60 at RBC Capital » 13:50 02/26/21 02/26 13:50 02/26/21 13:50 BRLXF Boralex $0.00 / + (+0.00%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research BRLXF Boralex $0.00 / + (+0.00%) 13:09 Today National Bank Boralex upgraded to Outperform from Sector Perform at National Bank 11:20 Today TD Securities Boralex price target lowered to C$55 from C$59 at TD Securities 06:05 Today CIBC Boralex upgraded to Outperformer from Neutral at CIBC 01/27/21 Raymond James Boralex downgraded to Outperform from Strong Buy at Raymond James
Recommendations	Baytex Energy price target raised to C$1.50 from C$1.20 at RBC Capital » 13:50 02/26/21 02/26 13:50 02/26/21 13:50 BTEGF Baytex Energy $0.00 / + (+0.00%) RBC Capital analyst Greg… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BTEGF Baytex Energy $0.00 / + (+0.00%) 02/25/21 BMO Capital Baytex Energy price target raised to C$1.50 from C$1 at BMO Capital 02/25/21 Raymond James Baytex Energy price target raised to C$1.25 from C$1 at Raymond James 02/25/21 TD Securities Baytex Energy price target raised to C$1.30 from C$0.90 at TD Securities 02/25/21 National Bank Baytex Energy price target raised to C$1.75 from C$1.50 at National Bank

Hot Stocks	Cantex says Chimerix reported 'promising results' from COVID-19 trial » 13:48 02/26/21 02/26 13:48 02/26/21 13:48 CMRX Chimerix $10.13 / -0.61 (-5.68%) Cantex Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events CMRX Chimerix $10.13 / -0.61 (-5.68%) 02/23/21 Point72 Asset Management reports 5.0% passive stake in Chimerix 01/08/21 Chimerix acquires Oncoceutics for $78M 12/07/20 Chimerix announces FDA acceptance of NDA for brincidofovir 11/05/20 Chimerix announces expected upcoming milestones CMRX Chimerix $10.13 / -0.61 (-5.68%) 01/11/21 H.C. Wainwright Chimerix price target raised to $16 from $7 at H.C. Wainwright 05/21/20 JonesTrading Chimerix initiated with a Buy at JonesTrading CMRX Chimerix $10.13 / -0.61 (-5.68%) 11/05/20 Chimerix reports Q3 EPS (18c), consensus (17c) 21 Jan CMRX Chimerix $10.13 / -0.61 (-5.68%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 12/07/20 Fly Intel: Pre-market Movers 03/01/21 41st Annual Healthcare Virtual Conference 04/07/21 PDUFA Date for Brincidofovir
Recommendations	Toronto-Dominion price target raised to C$88 from C$84 at CIBC » 13:47 02/26/21 02/26 13:47 02/26/21 13:47 TD Toronto-Dominion / + CIBC analyst Paul Holden… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals TD Toronto-Dominion / + 02/25/21 Toronto-Dominion reports Common Equity Tier 1 Capital ratio 13.6% 02/18/21 State Street appoints Theresa McLaughlin as global CMO 01/14/21 TD Bank Group to acquire Wells Fargo's Canadian Direct Equipment Finance unit 12/03/20 Toronto-Dominion reports Common Equity Tier 1 Capital ratio 13.1% TD Toronto-Dominion / + 13:17 Today National Bank Toronto-Dominion price target raised to C$82 from C$75 at National Bank 12:40 Today Scotiabank Toronto-Dominion price target raised to C$91 from C$82 at Scotiabank 02/17/21 Scotiabank Toronto-Dominion price target raised to C$82 from C$80 at Scotiabank 02/16/21 Barclays Toronto-Dominion price target raised to C$75 from C$72 at Barclays TD Toronto-Dominion / + 02/25/21 Toronto-Dominion reports Q1 adjusted EPS C$1.83 vs. C$1.66 last year 12/03/20 Toronto-Dominion reports Q4 adjusted EPS C$1.60 vs. C$1.59 last year 08/27/20 Toronto-Dominion reports Q3 adjusted EPS C$1.25 vs. C$1.79 last year TD Toronto-Dominion / + 01/29/21 TD customers hit with fradulent DoorDash charges, CBC reports
Recommendations	Stantec price target raised to C$56 from C$52 at CIBC » 13:46 02/26/21 02/26 13:46 02/26/21 13:46 STN Stantec $39.67 / +0.9 (+2.32%) CIBC analyst Jacob Bout… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings STN Stantec $39.67 / +0.9 (+2.32%) 02/23/21 Stantec and Hensel Phelps selected by WMATA for $225M project 02/16/21 Stantec signs agreement to acquire GTA Consultants 12/03/20 Stantec signs LOI to acquire Wenck environmental engineering firm 11/24/20 Stantec selected for PDS services for new South Niagara Hospital in Ontario STN Stantec $39.67 / +0.9 (+2.32%) 12:39 Today Scotiabank Stantec price target raised to C$59 from C$57 at Scotiabank 11:28 Today TD Securities Stantec price target raised to C$60 from C$50 at TD Securities 02/11/21 Scotiabank Stantec price target raised to C$57 from C$46 at Scotiabank 02/09/21 Desjardins Stantec price target raised to C$56 from C$47 at Desjardins STN Stantec $39.67 / +0.9 (+2.32%) 11/04/20 Stantec sees FY20 revenues slightly below FY19 level 11/04/20 Stantec reports Q3 EPS 62c, consensus 35c
Recommendations	Quebecor price target raised to C$40 from C$38 at CIBC » 13:46 02/26/21 02/26 13:46 02/26/21 13:46 QBCRF Quebecor $0.00 / + (+0.00%) CIBC analyst Robert Bek… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research QBCRF Quebecor $0.00 / + (+0.00%) 12:33 Today Scotiabank Quebecor price target raised to C$39 from C$38 at Scotiabank 01/06/21 Canaccord Quebecor downgraded to Hold from Buy at Canaccord 11/06/20 CIBC Quebecor price target raised to C$38 from C$36 at CIBC 11/06/20 Canaccord Quebecor price target raised to C$36 from C$35 at Canaccord
Recommendations	Pembina Pipeline price target lowered to C$39 from C$40 at CIBC » 13:46 02/26/21 02/26 13:46 02/26/21 13:46 PBA Pembina Pipeline $25.74 / -1.765 (-6.42%) CIBC analyst Robert… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events PBA Pembina Pipeline $25.74 / -1.765 (-6.42%) 02/25/21 Pembina Pipeline announces share repurchase program 01/19/21 Pembina Pipeline announces binding open season 12/14/20 Pembina Pipeline sees FY21 CapEx $730M 12/14/20 Pembina Pipeline sees 2021 adjusted EBITDA $3.2B-$3.4B PBA Pembina Pipeline $25.74 / -1.765 (-6.42%) 02/09/21 Scotiabank Pembina Pipeline downgraded to Sector Perform from Outperform at Scotiabank 01/27/21 Credit Suisse Pembina Pipeline price target raised to C$42 from C$40 at Credit Suisse 01/27/21 National Bank Pembina Pipeline price target raised to C$38 from C$36 at National Bank 01/22/21 Stifel Pembina Pipeline price target raised to C$37 from C$34 at Stifel PBA Pembina Pipeline $25.74 / -1.765 (-6.42%) 02/25/21 Pembina Pipeline reports Q4 EPS ($2.28), may not compare to consensus 44c 10:00 Today Pembina Pipeline - PBA

Recommendations	Nuvista Energy price target raised to C$2.25 from C$1.25 at CIBC » 13:45 02/26/21 02/26 13:45 02/26/21 13:45 NUVSF Nuvista Energy $0.00 / + (+0.00%) CIBC analyst Dennis Fong… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research NUVSF Nuvista Energy $0.00 / + (+0.00%) 13:03 Today National Bank Nuvista Energy upgraded to Outperform from Sector Perform at National Bank 12:32 Today Scotiabank Nuvista Energy price target raised to C$2.20 from C$1.50 at Scotiabank 11:27 Today TD Securities Nuvista Energy price target raised to C$2 from C$1 at TD Securities 02/19/21 National Bank Nuvista Energy price target raised to C$2.50 from C$1.25 at National Bank
Options	AppHarvest Inc call volume above normal and directionally bullish » 13:45 02/26/21 02/26 13:45 02/26/21 13:45 APPH AppHarvest $32.38 / -0.98 (-2.94%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options APPH AppHarvest $32.38 / -0.98 (-2.94%) 02/01/21 AppHarvest, Novus Capital Corp. complete business combination APPH AppHarvest $32.38 / -0.98 (-2.94%) 02/11/21 Fly Intel: Top five analyst initiations 02/11/21 Cowen AppHarvest appealing to food and water investors, Cowen starts with Outperform 02/11/21 Cowen AppHarvest initiated with an Outperform at Cowen APPH AppHarvest $32.38 / -0.98 (-2.94%) 02/23/21 AppHarvest Inc call volume above normal and directionally bullish 02/05/21 Largest borrow rate increases among liquid names 02/01/21 Three new option listings and five option delistings on February 1st
Periodicals	GM to furlough workers at Brazil plant for at least 20 days, Reuters reports » 13:44 02/26/21 02/26 13:44 02/26/21 13:44 GM General Motors $51.42 / +0.81 (+1.60%) General Motors will… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GM General Motors $51.42 / +0.81 (+1.60%) 02/25/21 Caterpillar elects Gerald Johnson to board of directors 02/17/21 EU passenger car registrations down 24.0% in January 02/16/21 Berkshire Hathaway buys Verizon, exits Barrick Gold in Q4 02/16/21 Cooperman's Omega Advisors buys GM, exits Lee in Q4 GM General Motors $51.42 / +0.81 (+1.60%) 02/19/21 Morgan Stanley GM's 'hidden gems' drawing rising investor interest, says Morgan Stanley 02/18/21 Citi General Motors price target raised to $85 from $70 at Citi 02/16/21 Wedbush Wedbush expects Apple to announce formal EV partnership in 2021 02/11/21 RBC Capital General Motors price target raised to $67 from $52 at RBC Capital GM General Motors $51.42 / +0.81 (+1.60%) 02/10/21 General Motors sees FY21 EBIT-adjusted of $1.5B-$2B 02/10/21 General Motors reports Q4 International EBIT-adjusted of $0.3B 02/10/21 General Motors sees FY21 adjusted EPS $4.50-$5.25, consensus $5.89 02/10/21 General Motors reports Q4 GM North America EBIT-adjusted of $2.6B GM General Motors $51.42 / +0.81 (+1.60%) 02/24/21 GM CFO believes worst of global chip shortage is over, CNBC reports 02/24/21 Biden to address chip shortages with executive action, WSJ reports 02/02/21 'Apple Car' to use E-GMP platform from Hyundai, Apple Insider reports 01/29/21 SoftBank CEO sees mass output of self-driving cars in two years, Reuters says GM General Motors $51.42 / +0.81 (+1.60%) 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 02/10/21 Fly Intel: Pre-market Movers 03/05/21 General Motors - GM GM General Motors $51.42 / +0.81 (+1.60%) 01/28/21 General Motors call volume above normal and directionally bullish 01/20/21 Notable open interest changes for January 20th 01/19/21 Early notable gainers among liquid option names on January 19th 01/13/21 Early notable gainers among liquid option names on January 13th
Recommendations	Maple Leaf Foods price target raised to C$37 from C$35 at CIBC » 13:43 02/26/21 02/26 13:43 02/26/21 13:43 MLFNF Maple Leaf Foods / + CIBC analyst Mark Petrie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research MLFNF Maple Leaf Foods / + 12:31 Today Scotiabank Maple Leaf Foods price target raised to C$36.50 from C$34 at Scotiabank 02/01/21 RBC Capital Maple Leaf Foods price target lowered to C$33 from C$34 at RBC Capital 10/28/20 BMO Capital Maple Leaf Foods upgraded to Outperform from Market Perform at BMO Capital 10/28/20 CIBC Maple Leaf Foods price target lowered to C$35 from C$40 at CIBC
Recommendations	Loblaw price target lowered to C$78 from C$82 at CIBC » 13:43 02/26/21 02/26 13:43 02/26/21 13:43 LBLCF Loblaw $0.00 / + (+0.00%) CIBC analyst Mark Petrie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research LBLCF Loblaw $0.00 / + (+0.00%) 12:29 Today Scotiabank Loblaw price target lowered to C$72 from C$76 at Scotiabank 02/04/21 National Bank Loblaw price target lowered to C$76 from C$82 at National Bank 01/22/21 RBC Capital Loblaw price target lowered to C$95 from C$106 at RBC Capital 01/08/21 TD Securities Loblaw price target lowered to C$70 from C$78 at TD Securities

Events

Earnings calls, analyst events, roadshows and more

IIIV
Today at 14:30

i3 Verticals, Inc. Firm Sponsored Meetings

40 Burton Hills Blvd., Suite 415, Nashville, TN
Today at 15:00

Farm Prices Y/Y: January 2021 Government Event
Today at 15:00

Farm Prices M/M: January 2021 Government Event
JLL
Today at 15:00

REITs;Financials Industry Meetings
Tomorrow at 00:00

AAAAI Virtual Annual Meeting 2021 Conferences

Virtual Meeting
CRMD
2021-02-28 at 00:00

PDUFA Date for Defencath Government Event
ATNX
2021-02-28 at 00:00

PDUFA Date for Oral Paclitaxel & Encequidar Government Event
2021-02-28 at 00:00

AAAAI Virtual Annual Meeting 2021 Conferences

Virtual Meeting
OOMA
2021-03-01 at 00:00

Ooma - OOMA Conference Calls
DMYD
2021-03-01 at 00:00

dMY Technology II - DMYD Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

BioNTech, Pfizer receive German regulatory approval for COVID-19 vaccine trial

TODAY'S FREE FLY STORIES

Get Full Fly Access